Beyond enhancing NLRP3 expression through FcγRs/NF-κB signaling (33), CRP promotes diabetic nephropathy progression through Smad3-mediated activation of NLRP3 inflammasomes (34). This evidence concerns the gene NFKB1 and diabetic kidney disease.